Found 9 matching trials
COVID-19 Vaccines Safety Tracking (CoVaST)
N/AThis project aims to monitor the side effects of COVID-19 vaccines worldwid...
Location
American College of Physicians
Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]
PHASE4PRIBIVAC will assess a heterologous prime-boost-boost strategy in compariso...
Location
National Centre for Infectious Diseases (NCID)
Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers
N/ARationale: Early in the covid-19 pandemic, it was unclear whether and how i...
Location
National Institute for Research in Tuberculosis
Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
PHASE3Group 1 (BBV154): In this group, 3000 participants will be recruited, rando...
Location
VIMS (Visakha Institute of Medical Sciences)
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
PHASE2A randomized, observer-blind, placebo-controlled immuno-bridging, and broad...
BBV152/BBV154 Heterologus Prime-Boost Study
PHASE2All participants will be assessed for immunogenicity and safety endpoints a...
Location
The INCLEN Trust International/Guru Nanak Hospital
Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
PHASE3A total sample size of 875 healthy volunteers ages ≥18 years will be recrui...
Location
All India Institute of Medical Sciences
COVAXIN in a Pediatric Cohort
PHASE2The study is designed to evaluate the safety, reactogenicity and immunogeni...
Location
Victoria Government Hospital
Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older
N/AThis Expanded Access, Phase 3, open label study is intended to provide acce...
Status
No Longer Available